News & Updates
Filter by Specialty:
Show Multimedia Only

RA onset delayed through 4 years with 1-year abatacept treatment in at-risk individuals
16 Jul 2025
byMike Ng
A 12-month therapeutic intervention with self-administered abatacept can delay the onset of rheumatoid arthritis (RA) in at-risk individuals for up to 4 years, according to results from the ALTO follow-up study presented at EULAR 2025.
RA onset delayed through 4 years with 1-year abatacept treatment in at-risk individuals
16 Jul 2025
Exercise prevents death in diabetes patients with MI
15 Jul 2025
byStephen Padilla
Regularly engaging in any physical activity (PA) can help reduce the risk of death in patients with diabetes and myocardial infarction (MI), suggests a study presented at ADA 2025.
Exercise prevents death in diabetes patients with MI
15 Jul 2025
Nontargeted better than targeted screening at identifying HCV cases in EDs
14 Jul 2025
byJairia Dela Cruz
A non–risk-based screening approach for hepatitis C virus (HCV) infection in the emergency department (ED), where all eligible patients were offered rapid testing, improves the identification of new infections when compared with a targeted approach of narrowly focusing on at-risk groups, according to the DETECT Hep C trial.